Uprizing 2.0 Recalled because it Contains Superdrol Banned by the FDA

The US FDA informs consumers that Uprizing 2.0 is recalled because it contains an undeclared drug ingredient, superdrol which is a synthetic steroid that may cause serious health consequences including heart attack and death.

Background of Uprizing 2.0

Uprizing 2.0, by Superior Metabolic Technologies Inc., is sold as a testosterone booster.

Its distribution covered retail health food stores in Texas, South Carolina, New Jersey, Mississippi, Georgia, California, Arizona and Alabama. FDA Alert on Uprizing 2.0

FDA’s reason for the recall is that according to lab analysis, Uprizing 2.0 was found to contain an undeclared drug ingredient, superdrol which is banned by the FDA.

Superdrol is a synthetic steroid and it can cause serious health consequences including acute liver injury, stroke, heart attack and death.

Recommendation on Uprizing 2.0

“Consumers who purchased Uprizing 2.0 are urged to return it to the place of purchase.”

Contacting the FDA to report cases with Uprizing 2.0

In case of detection of adverse events or side effects related to the use of Uprizing 2.0, healthcare professionals and patients should report it to the FDA’s MedWatch Safety Information and Adverse Event Reporting program through any of the following ways:

The report can be completed and submitted online at: www.fda.gov/MedWatch/report.htm

The form can be downloaded or requested by calling 1-800-332-1088, then completed and returned on the address indicated on the form

The completed form can be faxed to: 1-800-FDA-0178

AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.